Physician profile
E P Roy
NPI 1164485397
$6,122.90
in general payments reported to CMS, 2019-2025
46 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,201 · 2020: $583 · 2021: $1,169 · 2022: $1,192 · 2023: $1,205 · 2024: $307 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,978.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,657.70 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Abbvie INC. | $1,173.35 | 2019-2025 | Ubrelvy, Botox, Duopa |
| Acadia Pharmaceuticals INC | $309.88 | 2019-2023 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $287.48 | 2019-2023 | |
| Emd Serono, INC. | $225.32 | 2019-2025 | Mavenclad |
| Lundbeck LLC | $205.40 | 2019-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $178.28 | 2019-2024 | Emgality, Reyvow, Amyvid |
| Mdd US Operations, LLC | $144.71 | 2019-2024 | Gocovri, Gocovri |
| Biogen, INC. | $139.89 | 2019-2023 | Tysabri |
| Ucb, INC. | $135.66 | 2019-2022 | |
| Celgene Corporation | $133.43 | 2021-2023 | Zeposia |
| Amneal Pharmaceuticals LLC | $124.62 | 2019-2024 | Rytary |
| Supernus Pharmaceuticals, INC. | $116.75 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $92.70 | 2019-2023 | Ultomiris |
| Amgen INC. | $80.86 | 2019-2023 | Aimovig |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw E Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.